We wish everyone around the world a wonderful New Year filled with joy, peace and love. Thank you for being part of our journey this past year – our hearts are with you, wherever you are.
Here's to a brighter 2025 for us all! 💫
#HappyHolidays#HappyNewYear#ThankYou
Our Half-Yearly Financial Report 2024 & Q2 2024 figures are out. In Q2, we generated sales of €1.5 billion. EBITDA is at €160 million. Capital expenditures amount to €177 million, up 22 percent year on year. https://t.co/afFNtPRKAR
Groundbreaking! Today we officially started groundwork for our new #siliconesplant in Karlovy Vary – a milestone for the expansion of our production network in Europe.
The triple digit million euro #investment will create 200 new jobs in the region. Click https://t.co/YOkAKJfZsL
Together with CordenPharma, we are proud to serve the German government in its #pandemicpreparedness plans, officially entering the pandemic readiness state as of 1 June 2024. The companies are now in stand-by phase for at least five years https://t.co/7IkaKMIVB2
#mRNA
We today held our 18th #AnnualShareholdersMeeting as a virtual event.
- Dividend payment of € 3.00 per share
- Outlook for full-year 2024 confirmed
Learn more in our press release here https://t.co/gBTElqJdvS
#Hauptversammlung#HV#IR#WCH#WACKER
Wacker Chemical Corporation under new management +++
Christoph Kowitz takes charge of our U.S. subsidiary Wacker Chemical Corporation (#WCC) today. He succeeds David Wilhoit, who has been WCC's CEO since 2015.
Learn more in our #pressrelease https://t.co/PPu9OinJDu
We stay below prior-year figures amid lower selling prices in Q1. Learn more in our press release here 👉 https://t.co/xmRL2xPUlF
#WACKER#stakeholder#pressrelease#IR#WCH#Q1
FY2023 results are here: WACKER ended 2023 with €6.4 billion in sales and an EBITDA of €824 million. Capital expenditure amounted to €710 million. We expect a slight decline in sales and earnings for 2024 amid continuing weak market conditions. For more https://t.co/IGmLdBq8u3
Hello from Silicone Expo Europe 2024 in Amsterdam! We are presenting silicone-based solutions for electromobility and medical applications.
Learn more in our press release here https://t.co/F77ShAyrvU
#SiliconeExpoEU#SiliconeIndustry#Silicone#LSR#Amsterdam
Preliminary Figures: We close 2023 below previous year amid weak market environment.
Learn more in our press release here https://t.co/LIljrTOdB0
#IR#WCH#Wacker
We plan to further expand our silicone specialties business and are reorganizing our production operations in Europe.
A new production site for #silicones is to be built in Karlovy Vary in the Czech Republic. Learn more in our #pressrelease here https://t.co/sXXQGlcHvd
We see sales and earnings decline significantly in Q3 2023 due to persistently difficult market environment.
Learn more in our press release here:
https://t.co/WGbSbm6mqA
#WACKER#stakeholder#IR#WCH#Q3#pressrelease
Today, we held a grand ceremony in Shanghai to celebrate the 30th anniversary of our Chinese subsidiary. Starting in 1993, WACKER China now operates four production sites, eight sales offices & two technical centers. Congratulations on 30 years of success! https://t.co/07ilQAGKUE
We celebrate our Nünchritz site’s 25th anniversary. With over 1,500 employees in Saxony, we are the state´s largest chemical-industry employer. Learn more in our press release here https://t.co/LLSoFaqVW7
#Nünchritz#Saxony#WACKER#pressrelease#25thanniversary
We recently expanded our production of hyperpure #HCl at our #Burghausen site. Good news for the #semiconductor industry which needs ultrapure HCl as an etching & cleaning agent! Our capacity expansion will allow us to meet that demand going forward. Click https://t.co/arU2KB8CPY
We are happy to announce our collaboration with Caeregen!
Caeregen Therapeutics and Wacker Biotech will collaborate on the development and production of CTR-107 (Noregen™), a novel regenerative therapeutic for the treatment of retinal-related vision loss https://t.co/CGKTF8Ughb